Sun Pharma, USV and Cipla deepen wellness bets as GLP-1 demand reshapes nutrition

Indian drugmakers are expanding into nutraceuticals and consumer wellness, positioning supplements alongside rising demand for GLP-1-led weight management. Sun Pharma bought Innovcare for ₹271.2 crore, while USV acquired a 79% stake in Nutritionalab for ₹1,583 crore.

— Source publishedWed, 9 Sept, 2026, 18:39 IST·First seen Wed, 9 Sept, 2026, 18:45 IST·Source The Hindu BusinessLine

What happened

Sun Pharmaceutical Industries · Indian drugmakers Sun Pharma, USV and Cipla are expanding into consumer wellness and nutraceuticals as GLP-1 weight-loss

Key facts

  • Sun Pharma acquisition of Innovcare Lifesciences: ₹271.2 crore for 100% stake
  • USV acquisition of Nutritionalab: ₹1,583 crore for 79% stake
  • Recent wellness-business deals: around ₹1,000-₹1,500 crore
  • Cipla acquired 100% of Inzpera Healthsciences
  • Kilitch plans a GLP-1 drug launch in December

Why this matters

The deals raise the competitive bar for wellness M&A, suggesting pharma and consumer-health buyers should prioritize credible brands, differentiated formulations and distribution assets linked to metabolic-health demand.

What to watch

  • Further acquisitions of Indian nutraceutical, protein or metabolic-health brands by pharmaceutical companies.
  • Launches explicitly positioned for GLP-1 users, including muscle-maintenance protein, fiber, hydration and micronutrient products.
  • Growth in GLP-1 prescriptions and obesity-management clinics in major Indian cities.
  • Expansion of consumer-health portfolios into pharmacy chains, hospitals, modern trade and quick-commerce platforms.
  • FSSAI or drug-regulator actions on nutraceutical efficacy, weight-loss claims, labeling or endorsements.
  • Evidence that acquired wellness brands achieve broader distribution and sustained revenue growth rather than remaining niche assets.
  • Sun Pharma, USV and Cipla pursue additional acquisitions or distribution partnerships in protein, gut health, women’s wellness, healthy aging and metabolic nutrition.
  • Pharmacy chains and e-pharmacies create GLP-1 support bundles combining prescriptions, diagnostics, diet consultations and supplements.
  • Consumer-health brands introduce subscription packs for protein, electrolytes, fiber, multivitamins and digestive support targeted at weight-management consumers.
  • FMCG and D2C nutrition companies increase medical-expert endorsements, clinical studies and pharmacy-channel distribution to defend against pharma entrants.
  • Retailers use consumer-health data to personalize promotions and allocate premium shelf space to clinically positioned wellness products.